Very Long-Term Functional Outcomes and Dependency in Children With Anti-NMDA Receptor Encephalitis

Li-Wen Chen1, Gemma Olivé-Cirera1, Elianet G Fonseca1

  • 1From the Group of Experimental Neuroimmunology (L.-W.C., G.O.-C., E.G.F., T.A., J.D.), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Caixa Research Institute, Barcelona, Spain; Department of Pediatrics (L.-W.C.), National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Pediatric Neurology Unit (G.O.-C.), Hospital Parc Taulí de Sabadell; Neurology Service (E.G.F., J.D.), Hospital Clínic Barcelona; Pediatric Neuroimmunology Unit (E.G.F., T.A.), Neurology Department, Sant Joan de Déu Children's Hospital, Barcelona, Spain; Division of Neurology (M.M.S.), Hospital das Clinicas (HCFMUSP), Faculdade de Medicina, University of São Paulo, Brazil; Department of Neurology (T.I.), Kitasato University School of Medicine, Sagamihara, Japan; Centro de Investigación Biomédica en Red (J.D.), Enfermedades Raras (CIBERER), Spain; Department of Neurology (J.D.), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and University of Barcelona (J.D.), Barcelona, Spain.

Insights

Most children with anti-NMDA receptor encephalitis (NMDARe) recover well, but some face lasting behavioral and cognitive issues. Early disease onset in children increases the risk of severe, long-term deficits and dependency.

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology
  • Autoimmune Encephalitis

Background:

  • Anti-NMDA receptor encephalitis (NMDARe) is a severe autoimmune disorder affecting the central nervous system.
  • Long-term functional outcomes in pediatric NMDARe survivors are not fully understood.

Purpose of the Study:

  • To evaluate the long-term daily functioning of children diagnosed with NMDARe.
  • To identify factors influencing functional recovery in pediatric NMDARe patients.

Main Methods:

  • Retrospective study of pediatric patients (onset ≤18 years) with NMDARe.
  • Assessment of daily function using the 15-domain Liverpool Outcome Score by physicians.
  • Minimum follow-up duration of 5 years.

Main Results:

  • Of 76 patients, 68 were followed for a mean of 7.1 years; 11% mortality.
  • Full recovery observed in 73% of survivors.
  • Behavioral/school deficits in 18%, multidomain deficits in 9%.

Conclusions:

  • Most pediatric NMDARe patients achieve substantial functional recovery within 5 years.
  • A significant minority experience persistent deficits, particularly behavioral and cognitive.
  • Younger age at onset is a predictor of poorer outcomes and increased sociofamiliar dependence.
Abstract